Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» June 2013
June 2013
Generic Versions of AstraZeneca’s Pulmicort Respules Enjoined from Launch Pending Appeal in Patent Infringement Case
Generic Versions of AstraZeneca’s Pulmicort Respules Enjoined from Launch Pending Appeal in Patent Infringement Case
National Law Review
AstraZeneca
Pulmicort
generics
Patent Infringement
lawsuits
If You Are an Income Investor, You Will Love These Pharma Companies
If You Are an Income Investor, You Will Love These Pharma Companies
Motley Fool
GSK
Bristol-Myers Squibb
Merck
New clot preventer works as well as warfarin with less bleeding
New clot preventer works as well as warfarin with less bleeding
Reuters
anti-clotting
Eliquis
Warfarin
Pfizer
Bristol-Myers Squibb
Obama Administration Not Budging On Medicare Competitive Bidding
Obama Administration Not Budging On Medicare Competitive Bidding
Forbes
Obamacare
Are You Valuing This Biotechnology Company Correctly?
Are You Valuing This Biotechnology Company Correctly?
Motley Fool
Theravance
Alnylam Reports Positive Phase II Data for ALN-TTR02, an RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of TTR-Mediated Amyloidosis (ATTR)
Alnylam Reports Positive Phase II Data for ALN-TTR02, an RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of TTR-Mediated Amyloidosis (ATTR)
Yahoo/BusinessWire
ALN-TTR02
Alnylam
amyloidosis
TTR-mediated amyloidosis
The Hidden Way to Invest in Obesity
The Hidden Way to Invest in Obesity
Motley Fool
Orexigen
obesity
weight loss
Contrave
Woman Disfigured by Generic Drug Loses $21 Million Award
Woman Disfigured by Generic Drug Loses $21 Million Award
KVNU
legal
mutual pharmaceutical
generics
Taisho Pharma : New Agent for Osteoporosis Approved in Japan “Bonviva® IV Injection”
Taisho Pharma : New Agent for Osteoporosis Approved in Japan “Bonviva® IV Injection”
4 Traders
Tashio Pharma
osteoporosis
Japan
Bonviva
regulatory
FDA approves first non-hormonal treatment for menopausal hot flashes
FDA approves first non-hormonal treatment for menopausal hot flashes
Reuters
FDA
menopause
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »